Clinical Trials
5 trialsNCT05222516 2023-08-08
Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD
OM Pharma SA
Phase 2 Terminated
NCT03738423 2022-06-10
Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
Regeneron Pharmaceuticals
Phase 2 Terminated
NCT03736967 2021-11-01
Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Regeneron Pharmaceuticals
Phase 2 Terminated
NCT00557895 2019-11-25
Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders
National Institutes of Health Clinical Center (CC)
Terminated
NCT00129415 2015-05-22
Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions
University of Michigan
Phase 1/2 Terminated